Publications

Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage.

Authors: A Moumen, P Masterson, MJ O'Connor, SP Jackson

Research group: Jackson Group

E-pub date: 31 Oct 2024

Journal name: Cell

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Authors: BH Nelson, P Hamilton, MT Phung, K Milne, B Harris, S Thornton, D Stevens, ...

Research group: Brenton Group

E-pub date: 29 Oct 2024

Journal name: J Clin Invest

Angiogenic and Immune Predictors of Neoadjuvant Axitinib Response in Renal Cell Carcinoma with Venous Tumour Thrombus

Authors: R Wray, H Paverd, I Machado, J Barbieri, F Easita, AR Edwards, FA Gallagher...

Research group: de la Roche Group

E-pub date: 28 Oct 2024

Journal name:

CELL-INTRINSIC METABOLIC PHENOTYPES IDENTIfiED IN GLIOBLASTOMA PATIENTS USING MASS SPECTROMETRY IMAGING OF 13C-LABELED GLUCOSE METABOLISM

Authors: A Tsyben, A Dannhorn, G Hamm, DL Couturier, M Briggs, R Mair, K Brindle

Research group: Brindle Group

E-pub date: 15 Oct 2024

Journal name: Neuro-Oncology

Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis.

Authors: ID Sadien, S Adler, S Mehmed, S Bailey, A Sawle, D-L Couturier, M Eldridge,...

Research group: Winton Group, Bioinformatics

E-pub date: 1 Oct 2024

Journal name: Nature

Temporal recording of mammalian development and precancer.

Authors: M Islam, Y Yang, AJ Simmons, VM Shah, KP Musale, Y Xu, N Tasneem, Z Chen, L...

Research group: Winton Group

E-pub date: 1 Oct 2024

Journal name: Nature

EV358/#753 Establishing GO Hildas: a diversity-focused co-production group in gynaeoncology to improve health equity

Authors: J Mills, L Bird, K Munir, N Hutchinson-Pascal, G Funingana, M-L Alcaraz, J ...

Research group: Brenton Group

E-pub date: 1 Oct 2024

Journal name: International Journal of Gynecological Cancer

Clinical validation of a DNA methylation biomarker to predict overall survival of relapsed ovarian cancer patients

Authors: M Habiburrahman, N Masrour, N Patel, AM Piskorz, R Brown, JD Brenton, IA Mc...

Research group: Brenton Group

E-pub date: 27 Sep 2024

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage.

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Angiogenic and Immune Predictors of Neoadjuvant Axitinib Response in Renal Cell Carcinoma with Venous Tumour Thrombus

CELL-INTRINSIC METABOLIC PHENOTYPES IDENTIfiED IN GLIOBLASTOMA PATIENTS USING MASS SPECTROMETRY IMAGING OF 13C-LABELED GLUCOSE METABOLISM

Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis.

Temporal recording of mammalian development and precancer.

EV358/#753 Establishing GO Hildas: a diversity-focused co-production group in gynaeoncology to improve health equity

Clinical validation of a DNA methylation biomarker to predict overall survival of relapsed ovarian cancer patients

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage.

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer.

Angiogenic and Immune Predictors of Neoadjuvant Axitinib Response in Renal Cell Carcinoma with Venous Tumour Thrombus

CELL-INTRINSIC METABOLIC PHENOTYPES IDENTIfiED IN GLIOBLASTOMA PATIENTS USING MASS SPECTROMETRY IMAGING OF 13C-LABELED GLUCOSE METABOLISM

Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis.

Temporal recording of mammalian development and precancer.

EV358/#753 Establishing GO Hildas: a diversity-focused co-production group in gynaeoncology to improve health equity

Clinical validation of a DNA methylation biomarker to predict overall survival of relapsed ovarian cancer patients